Physician organization urges lawmakers to prioritize access to safe, approved medications
WASHINGTON – The Alliance for Patient Access (AfPA) made the following statement about the two Senate amendments regarding importation of prescription drugs from other countries that were voted down late last night.
STATEMENT FROM BRIAN KENNEDY, EXECUTIVE DIRECTOR, ALLIANCE FOR PATIENT ACCESS:
“Physicians are confident in the medications they prescribe to patients because they have undergone an extensive approval process by the Food and Drug Administration, which helps to make the U.S. drug market one of the safest in the world.
When medications from foreign countries enter the United States, that confidence is shaken. Because these drugs aren’t subject to FDA regulation, including meeting the standards for safety and efficacy, health care providers would have to consider the possibility of counterfeit medications and drugs of substandard quality.
Adulterating the U.S. drug supply with imported drugs that have not gone through FDA approval jeopardizes patient care and patient safety. We applaud the Senate for rejecting reimportation and urge lawmakers and government officials to continue to prioritize patients’ ability to access safe, FDA approved medicines.”
The Alliance for Patient Access is a national network of physicians dedicated to ensuring patient access to approved therapies and appropriate clinical care.